Product image of Moxifloxacina Mylan (Moxifloxacin) supplied by GNH India

Moxifloxacina Mylan

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxifloxacina Mylan (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxifloxacina Mylan, is a fluoroquinolone antibiotic presented as an oral formulation for systemic use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, skin and skin structure infections, and intra‑abdominal infections in adult patients.

GNH India supplies Moxifloxacina Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare providers worldwide.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxifloxacin is a fluoroquinolone antibiotic used to treat bacterial infections of the respiratory and other systems.

  • Community‑acquired bacterial pneumonia: eradicates causative pathogens and improves clinical outcomes.
  • Acute bacterial sinusitis: reduces sinus inflammation and bacterial load, leading to symptom relief.
  • Acute bacterial exacerbations of chronic bronchitis: resolves infection and helps prevent further deterioration.
  • Skin and skin structure infections: provides bacterial clearance in soft‑tissue infections.
  • Intra‑abdominal infections: contributes to eradication of mixed aerobic and anaerobic organisms.

How It Works

  • Moxifloxacin exerts its antibacterial activity by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. Binding to the quinolone‑resistance‑determining region of these enzymes prevents DNA strand separation, halting bacterial DNA synthesis and transcription, which leads to bacterial cell death.

Side Effects

Moxifloxacin may cause adverse reactions ranging from mild to severe.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools, usually self‑limiting.
  • Headache: transient cranial discomfort.
  • Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects

  • Tendon rupture: especially in the Achilles tendon.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Severe allergic reactions: anaphylaxis or angioedema.
  • Clostridioides difficile‑associated diarrhea: potentially life‑threatening colitis.

Precautions & Warnings

Before prescribing moxifloxacin, clinicians should consider several safety factors.

  • Renal or hepatic impairment: adjust therapy based on clinical judgment.
  • History of tendon disorders: avoid use due to risk of tendon rupture.
  • Cardiac arrhythmias: monitor QT interval, especially with other QT‑prolonging agents.
  • Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited.
  • Drug interactions: review concomitant medications for potential QT prolongation or CYP interactions.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Avoid Interactions

Moxifloxacin can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Concomitant use with other fluoroquinolones: increased risk of tendon toxicity.
  • Co‑administration with systemic corticosteroids: heightened tendon rupture risk.
  • Drugs that prolong QT interval (e.g., quinidine, macrolides): may cause serious cardiac arrhythmias.
  • Antacids containing aluminum or magnesium: significantly reduce absorption of moxifloxacin.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect; monitor INR.
  • Theophylline: possible increase in plasma concentrations; monitor for toxicity.

Frequently Asked Questions

Moxifloxacina Mylan, containing the fluoroquinolone moxifloxacin, is indicated for adult patients with community‑acquired bacterial pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, skin and skin structure infections, and intra‑abdominal infections caused by susceptible bacteria.

Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA supercoiling and replication. By binding to these enzymes, it blocks DNA synthesis and transcription, leading to bacterial cell death and eradication of the infection.

The dosage of Moxifloxacina Mylan is determined by the prescribing clinician based on the specific infection, severity, patient characteristics and local guidelines. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for moxifloxacin in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To request Moxifloxacina Mylan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Moxifloxacin offers a broader spectrum against Gram‑positive organisms and atypical pathogens compared with some older fluoroquinolones, and it has a once‑daily dosing schedule for many indications. However, safety considerations such as tendon toxicity and QT prolongation are shared across the class, so clinicians weigh efficacy against individual patient risk factors.

Moxifloxacina Mylan should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency.

Moxifloxacina Mylan is administered orally, typically as a tablet taken with a full glass of water. It may be taken with or without food, but antacids containing aluminum or magnesium should be spaced at least two hours apart to avoid reduced absorption.

Serious risks include tendon rupture (especially in the Achilles tendon), QT interval prolongation leading to potentially fatal arrhythmias, severe allergic reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Patients should be monitored closely for these events, particularly if they have pre‑existing risk factors.

Moxifloxacina Mylan should be avoided in patients with a known hypersensitivity to moxifloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and individuals with significant QT prolongation or uncontrolled cardiac arrhythmias. Caution is also advised for patients with severe renal or hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT